Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Fall Conference | C14 - Neurological Debate: Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy?

Saturday 10/26/24
10:00 AM - 11:30 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Epilepsy/Clinical Neurophysiology (EEG), General Neurology
By the end of this program, participants should be able to identify the clinical criteria for diagnosing epilepsy in patients with a single unprovoked seizure; evaluate the risks and benefits of treating patients with a single unprovoked seizure as if they have epilepsy; discuss the latest evidence and guidelines regarding the management of patients with a single unprovoked seizure; and formulate individualized treatment plans for patients presenting with a single unprovoked seizure, considering patient-specific factors and preferences.
1.50 CME credits
Medical Knowledge
Didactic

Program Materials

Event Timeline
10:00 AM - 10:45 AM PDT Speaker Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy? (yes)
Gregory D. Cascino, MD, FÂ鶹´«Ã½Ó³»­
10:45 AM - 11:30 AM PDT Speaker Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy? (no)
Anteneh M. Feyissa, MD, MSc, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
Gregory D. Cascino, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Anteneh M. Feyissa, MD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.